Mayne Pharma Group Ltd
ASX:MYX

Watchlist Manager
Mayne Pharma Group Ltd Logo
Mayne Pharma Group Ltd
ASX:MYX
Watchlist
Price: 3.13 AUD -2.19%
Market Cap: 254.3m AUD

Cash Flow Statement

Cash Flow Statement
Mayne Pharma Group Ltd

Rotate your device to view
Cash Flow Statement
Currency: AUD
Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025
Operating Cash Flow
Stock-Based Compensation
0
5
8
5
4
4
4
4
Cash Taxes Paid
(3)
7
4
(4)
(0)
(0)
(0)
13
Change in Working Capital
(23)
(32)
(63)
(39)
(0)
(3)
(33)
(33)
Cash from Operating Activities
13
N/A
(7)
N/A
(64)
-794%
(43)
+34%
(15)
+66%
(15)
-5%
0
N/A
17
+4 368%
Investing Cash Flow
Capital Expenditures
(20)
(12)
(223)
(220)
(19)
(21)
(12)
(29)
Other Items
(23)
(17)
685
693
82
74
(46)
(39)
Cash from Investing Activities
(43)
N/A
(29)
+34%
462
N/A
473
+2%
63
-87%
53
-15%
(59)
N/A
(68)
-16%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
(6)
(17)
(11)
0
0
Net Issuance of Debt
18
37
(331)
(376)
(51)
(15)
(4)
(4)
Cash Paid for Dividends
0
0
0
(45)
0
0
0
0
Other
(11)
(9)
(6)
(5)
1
6
4
3
Cash from Financing Activities
7
N/A
28
+313%
(338)
N/A
(432)
-28%
(113)
+74%
(20)
+82%
0
N/A
(1)
N/A
Change in Cash
Effect of Foreign Exchange Rates
7
7
1
(3)
(1)
(1)
3
1
Net Change in Cash
(17)
N/A
(1)
+92%
61
N/A
(4)
N/A
(66)
-1 535%
17
N/A
(56)
N/A
(50)
+10%
Free Cash Flow
Free Cash Flow
(7)
N/A
(19)
-188%
(287)
-1 406%
(262)
+9%
(34)
+87%
(36)
-6%
(12)
+67%
(12)
+4%